Related Experiment Video
Updated: Feb 13, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy
Salma I Patel1, Michael J Ackerman2, Fadi E Shamoun3
1a Center for Sleep Medicine , Mayo Clinic , Rochester , MN , USA.
Insights
Sudden cardiac death (SCD) risk in hypertrophic cardiomyopathy (HCM) is complex. Prolonged QTc interval on ECG is a significant predictor of SCD and death, even with other risk factors present.
Area of Science:
- Cardiology
- Clinical Electrophysiology
- Cardiovascular Research
Background:
- Sudden cardiac death (SCD) risk stratification in hypertrophic cardiomyopathy (HCM) is challenging.
- Electrocardiogram (ECG)-derived markers are crucial for assessing SCD risk in HCM patients.
Purpose of the Study:
- To evaluate ECG-derived risk factors for SCD in a large cohort of HCM patients.
- To determine the predictive value of the QTc interval for SCD and mortality in HCM.
Main Methods:
- Retrospective review of 1615 adult HCM patients evaluated at Mayo Clinic (2002-2012).
- Analysis of ECG and 24-hour Holter monitor data.
- Logistic regression models used to assess risk factors for SCD, including conventional factors and QTc interval.
Main Results:
- Increasing numbers of conventional risk factors significantly elevated SCD odds (OR 4.88 for 1, 6.92 for 2, 13.99 for 3+).
- A QTc interval > 450 ms was an independent predictor of SCD (OR 1.72) and death (HR 1.88).
- No correlation found between SCD and other ECG findings like arrhythmias or conduction blocks.
Conclusions:
- Prolonged QTc interval is a significant risk factor for SCD and mortality in HCM patients.
- ECG assessment, particularly QTc duration, aids in refining SCD risk prediction in HCM.
- QTc interval should be considered alongside conventional risk factors for comprehensive SCD risk assessment in HCM.
Introduction:
Risk assessment for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM) remains complex. The goal of this study was to assess electrocardiogram (ECG)-derived risk factors on SCD in a large HCM population Methods: Retrospective review of adults with HCM evaluated at Mayo Clinic, Rochester, MN from 1 December 2002 to 31 December 2012 was performed. Data inclusive of ECG and 24-hour ambulatory Holter monitor were assessed. SCD events were documented by ventricular fibrillation (VF) noted on implantable cardioverter defibrillator (ICD), or appropriate VT or VF-terminating ICD shock.
Results:
Overall, 1615 patients (mean age 53.7 ± 15.2 years; 943 males, 58.4%) were assessed, with mean follow-up 2.46 years and 110 SCD events. Via logistic regression (n = 820), the odds of SCD increased with increasing number of conventional risk factors. With one risk factor the OR was 4.88 (p < .0001; CI 2.22-10.74), two risk factors the OR was 6.922 (p < .0001; CI 2.94-16.28) and three or more risk factors, the OR was 13.997 (p < .0001; CI 5.649-34.68). Adding QTc > 450 to this logistic regression model had OR 1.722 (p = .04, CI 1.01-2.937) to predict SCD. QTc ≥ 450 was a significant predictor for death (HR 1.88, p = .021, CI 1.10-3.20). There was no correlation between sinus bradycardia, sinus tachycardia, first degree AV block, atrial fibrillation, left bundle branch block, right bundle branch block, premature atrial complexes, premature ventricular complexes, supraventricular tachycardia, PR interval, QRS interval and SCD.
Conclusions:
Prolonged QTc was a risk factor for SCD and death even when controlling for typical risk factors.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management